Home Other Building Blocks Ns 11394

Ns 11394

CAS No.:
693288-97-0
Catalog Number:
AG00FBZP
Molecular Formula:
C22H15ClN2O4
Molecular Weight:
406.8185
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$91
- +
5mg
95%
1 week
United States
$154
- +
10mg
95%
1 week
United States
$237
- +
50mg
95%
1 week
United States
$598
- +
100mg
95%
1 week
United States
$973
- +
Product Description
Catalog Number:
AG00FBZP
Chemical Name:
Ns 11394
CAS Number:
693288-97-0
Molecular Formula:
C22H15ClN2O4
Molecular Weight:
406.8185
MDL Number:
MFCD12912405
IUPAC Name:
N-[4-chloro-2-[(1,3-dioxoisoindol-2-yl)methyl]phenyl]-2-hydroxybenzamide
InChI:
InChI=1S/C22H15ClN2O4/c23-14-9-10-18(24-20(27)17-7-3-4-8-19(17)26)13(11-14)12-25-21(28)15-5-1-2-6-16(15)22(25)29/h1-11,26H,12H2,(H,24,27)
InChI Key:
UFOUABRZSDGGAZ-UHFFFAOYSA-N
SMILES:
Clc1ccc(c(c1)CN1C(=O)c2c(C1=O)cccc2)NC(=O)c1ccccc1O
Properties
Complexity:
633  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
406.072g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
406.822g/mol
Monoisotopic Mass:
406.072g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
86.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.1  
Literature
Title Journal
A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling. Molecular pharmacology 20130401
Effects of positive allosteric modulators on single-cell oscillatory Ca2+ signaling initiated by the type 5 metabotropic glutamate receptor. Molecular pharmacology 20091201
Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold. Bioorganic & medicinal chemistry letters 20080715
N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors. Molecular pharmacology 20080301
Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA. Bioorganic & medicinal chemistry letters 20070301
The effect of mGlu5 receptor positive allosteric modulators on signaling molecules in brain slices. European journal of pharmacology 20060501
Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Current topics in medicinal chemistry 20060101
Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes. The Journal of pharmacology and experimental therapeutics 20051201
A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. The Journal of pharmacology and experimental therapeutics 20050401
Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo. Journal of medicinal chemistry 20041118
A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain. The Journal of pharmacology and experimental therapeutics 20040501
Difference in mGluR5 interaction between positive allosteric modulators from two structural classes. Annals of the New York Academy of Sciences 20031101
Properties